
In this episode we discuss psychedelics and how they can be used in depression in a case study. We also discuss how personalised medicine can manifest itself and the implications in today's society
Paper Discussed Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
References: Proven Dopamine production(awesome !) after placebo more than 200% compared to baseline
Spontaneous remissions : Kelly A Turner, University of Berkeley
Findings used in Cancer treatment approaches
Recorded at the CDI studio in the IoPPN (Institute of Psychiatry, Psychology and Neuroscience) at King's College London.